Atlas Trials

Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis

Clinical trial NCT05640037 · COMPLETED

Trial details

NCT number
NCT05640037
Sponsor
Zhongnan Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Sepsis
Start date
2022-03-23
Primary completion
2024-03-20
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.